Proteomics in pancreatic cancer

Abstract Pancreatic cancer (PC), one of the most aggressive malignancies, is characterized by a dismal prognosis owing to its low early detection rates, rapid progression, frequent postoperative complications, and limited efficacy of conventional oncological therapies. The fact that most patients ar...

Full description

Bibliographic Details
Published in:Biomarker Research
Main Authors: Fei Cai, Yufan Gu, Yingying Ling, Guanhua Yi, Shengze Zang, Tao Su, Yueqiu Liu, Ang Li, Denian Wang, Wanjun Zhao, Xinfang Xie, Guisen Li, Lunzhi Dai, Meng Gong, Hao Yang, Yang Zhao, Yong Zhang
Format: Article
Language:English
Published: BMC 2025-07-01
Subjects:
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Proteomics
Mass spectrometry
Biomarkers
Online Access:https://doi.org/10.1186/s40364-025-00805-y

Internet

https://doi.org/10.1186/s40364-025-00805-y

Similar Items